At the time of writing, ORIC Pharmaceuticals Inc [ORIC] stock is trading at $12.12, up 5.21%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ORIC shares have gain 32.46% over the last week, with a monthly amount glided 32.89%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ORIC Pharmaceuticals Inc [NASDAQ: ORIC] stock has seen the most recent analyst activity on January 07, 2026, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $22. Previously, Evercore ISI started tracking the stock with Outperform rating on November 20, 2025, and set its price target to $25. On November 18, 2025, Wolfe Research initiated with a Peer Perform rating. Ladenburg Thalmann initiated its recommendation with a Buy and recommended $15 as its price target on July 08, 2025. Wells Fargo started tracking with an Overweight rating for this stock on October 31, 2024, and assigned it a price target of $20. In a note dated September 06, 2024, Stifel initiated a Buy rating and provided a target price of $20 on this stock.
For the past year, the stock price of ORIC Pharmaceuticals Inc fluctuated between $3.90 and $14.93. Currently, Wall Street analysts expect the stock to reach $22 within the next 12 months. ORIC Pharmaceuticals Inc [NASDAQ: ORIC] shares were valued at $12.12 at the most recent close of the market. An investor can expect a potential return of 81.52% based on the average ORIC price forecast.
Analyzing the ORIC fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is -0.45 and Total Capital is -0.36. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that ORIC Pharmaceuticals Inc [NASDAQ:ORIC] has a current ratio of 14.65. Further, the Quick Ratio stands at 14.65, while the Cash Ratio is 2.46.
Transactions by insiders
Recent insider trading involved Richard A, Heyman, Director, that happened on Jan 16 ’26 when 6400.0 shares were purchased. Director, Richard A, Heyman completed a deal on Jan 16 ’26 to buy 7000.0 shares. Meanwhile, Chief Medical Officer Multani Pratik S sold 10720.0 shares on Dec 16 ’25.
